Leucovorin enhancement of the effects of the fluoropyrimidines on thymidylate synthase
- PMID: 2521810
- DOI: 10.1002/1097-0142(19890315)63:6+<1008::aid-cncr2820631303>3.0.co;2-z
Leucovorin enhancement of the effects of the fluoropyrimidines on thymidylate synthase
Abstract
Exposure of tumor cells to reduced folates before or with the fluoropyrimidines, 5-fluorouracil or 5-fluoro-2'deoxyuridine, results in a substantial increase in the activity of these drugs. Available evidence suggests that the mechanism of this synergism is a kinetic stabilization of complex formed between thymidylate synthase and fluorodeoxyuridylate that also involves a mole of the cofactor for the thymidylate synthase reaction, 5,10-methylenetetrahydrofolate. This effect results in an extended time of depletion of thymidine nucleotides with a resultant increased level of cell death. The biochemical aspects of this interaction are discussed and related to the therapeutics of this combination.
Similar articles
-
Tumor cell responses to inhibition of thymidylate synthase.Adv Exp Med Biol. 1988;244:71-83. doi: 10.1007/978-1-4684-5607-3_7. Adv Exp Med Biol. 1988. PMID: 2977717
-
Mechanisms of resistance to fluoropyrimidines.Semin Oncol. 1992 Apr;19(2 Suppl 3):4-9. Semin Oncol. 1992. PMID: 1532673
-
Potentiation of 5-fluorouracil induced inhibition of thymidylate synthase in human colon tumors by leucovorin is dose dependent.Adv Exp Med Biol. 1993;338:613-6. doi: 10.1007/978-1-4615-2960-6_126. Adv Exp Med Biol. 1993. PMID: 8304192 No abstract available.
-
Modulation of fluoropyrimidines by leucovorin: rationale and status.J Surg Oncol Suppl. 1991;2:116-23. doi: 10.1002/jso.2930480525. J Surg Oncol Suppl. 1991. PMID: 1832538 Review.
-
The role of interferon-alpha as a modulator of fluorouracil and leucovorin.Eur J Cancer. 1995 Jul-Aug;31A(7-8):1316-20. doi: 10.1016/0959-8049(95)91267-g. Eur J Cancer. 1995. PMID: 7577043 Review.
Cited by
-
Biochemical modulation of 5-fluorouracil with or without leucovorin by a low dose of brequinar in MGH-U1 cells.Cancer Chemother Pharmacol. 1992;30(5):370-6. doi: 10.1007/BF00689965. Cancer Chemother Pharmacol. 1992. PMID: 1380407
-
miRNAs and lncRNAs as Predictive Biomarkers of Response to FOLFOX Therapy in Colorectal Cancer.Front Pharmacol. 2018 Aug 6;9:846. doi: 10.3389/fphar.2018.00846. eCollection 2018. Front Pharmacol. 2018. PMID: 30127741 Free PMC article. Review.
-
Phase II study of 5-fluoruracil leucovorin and azidothymidine in patients with metastatic colorectal cancer.J Cancer Res Clin Oncol. 1996;122(9):554-8. doi: 10.1007/BF01213552. J Cancer Res Clin Oncol. 1996. PMID: 8781570 Free PMC article. Clinical Trial.
-
Structural insights of human N-acetyltransferase 10 and identification of its potential novel inhibitors.Sci Rep. 2021 Mar 15;11(1):6051. doi: 10.1038/s41598-021-84908-0. Sci Rep. 2021. PMID: 33723305 Free PMC article.
-
Sequence-dependent cytotoxic effects of the combination of a new nitrosourea, fotemustine, with 5-fluorouracil plus folinic acid.Cancer Chemother Pharmacol. 1991;28(6):448-54. doi: 10.1007/BF00685821. Cancer Chemother Pharmacol. 1991. PMID: 1657424